DawnAFishbeinMD

Infectious Disease • Washington, DC

HIV/AIDS Medicine

Medical Director, DC Partnership for HIV/AIDS Progress Subspecialty Clinics

Join to view full profile

Dr. Fishbein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fishbein's full profile

Already have an account?

Office
110 Irving St Nw
Ste 2a56
Washington, DC 20010
Phone+1 202-877-7164

Fax+1 202-877-0341

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 2001 - 2004
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1998 - 2001
Albert Einstein College of MedicineClass of 1998

Certifications & Licensure

DC State Medical License 2009 - 2024
NY State Medical License 1999 - 2020
MD State Medical License 2010 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

3 citations
HCV universal EHR prompt successfully increases screening, highlights potential disparities.
Benjamin Hack, Kavya Sanghavi, Sravya Gundapaneni, Stephen Fernandez, Justin Hughes
Plos One. 2023-01-01
3 citations
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Mark S. Sulkowski, Juhi S Moon, Kenneth E. Sherman, Giuseppe Morelli, Jama M. Darling
Hepatology. 2021-08-26
3 citations
Use of direct-acting antivirals for hepatitis C viral infection and association with intrahepatic cholangiocarcinoma: Is there a linkage?
Anusha Vakiti, Min Ho Cho, Wen Lee, John Liang, Alexander T. Lalos
Journal of Oncology Pharmacy Practice. 2019-10-01

Abstracts/Posters

Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma
Dawn Fishbein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Grant Support

Protective Immunity To HBV In HIV+ Patients With Isolated Hepatitis BNational Center For Research Resources2009
Protective Immunity To HBV In HIV+ Patients With Isolated HBV Core AntibodyNational Center For Research Resources2008
Pre-Chemotherapeutic Care Of HCV Infected Drug UsersNational Institute On Drug Abuse2004–2008